AtheroGenics Reports Clinical Data On Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, At American Diabetes Association Annual Meeting
AtheroGenics, Inc. (NASDAQ: AGIX) announced that data from its 6, 144-patient ARISE Phase 3 clinical study of AGI-1067 (succinobucol) were presented at the 68th Scientific Sessions of the American Diabetes Association (ADA) in San Francisco, California.
Sequencing Companies Join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research.
Hope For Treating The Most Infectious And Neglected Diseases - Visceral Leishmaniasis, Chagas Disease, And Sleeping Sickness
The Paris-based Institut de Recherche pour le D~A veloppement (IRD) and DNDi announced the implementation of scientific cooperation projects for developing treatments against visceral leishmaniasis, Chagas disease, and sleeping sickness.
Better Outlook For Patients With Oesophago-Gastric Cancer But Palliative Services Still Need To Improve, Says First National Audit, UK
Patients with one of the most devastating forms of cancer are surviving longer due to better services, but more work still needs to be done to improve organisation of palliative care, says the first national Oesophago-Gastric (OG) Cancer Audit.
The Number Of Disabled Children Living In Poverty Rises
New child poverty figures released show a small increase in child poverty across the county. There has been an increase of 100, 000 children living in poverty from 2005/6 to 2006/7, despite the government's promise to halve child poverty by 2010.
Astrazeneca Submits Seroquel XR trade; In Europe For The Treatment Of Major Depressive Disorder
AstraZeneca announced that the company has submitted applications in the European Union (EU) for once-daily SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR), seeking approval for the treatment of major depressive disorder (MDD) including maintenance therapy in adult patients using Mutual Recognition Procedure (MRP).
National Glaucoma Awareness Week: 9th - 15th June 2008
Are you over 40? Is glaucoma in your family? Are you African-Caribbean? Are you short sighted? Do you have diabetes? If the answer is yes to any of these questions, you definitely should have your eyes tested regularly. Primary open angle glaucoma (POAG) has no symptoms, but slowly and painlessly it destroys sight if it is not detected and treated.
CRfocus Joins COPE In Fight Against Publication Misconduct, UK
The Institute of Clinical Research (ICR) is celebrating this month after its in-house magazine, CRfocus, was accepted as a member of the Committee on Publication Ethics (COPE). Formed in 1997, COPE is a forum for editors of peer-reviewed journals to discuss issues related to the integrity of the scientific record.
Rheumatoid Arthritis - New Data Also Proves MabThera's Inhibition Of Joint Damage Is Maintained Over Two Years
A recent study [1] has called into question the practice of putting rheumatoid arthritis (RA) patients onto a second tumour necrosis factor (TNF) inhibitor therapy, a commonly used class of RA drugs, when they do not respond to the first TNF inhibitor.
Sleep Is Poor Among Hospitalized Pediatric Patients And Their Parents
A research abstract presented on Tuesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS), is one of the first to demonstrate the negative impact of hospitalization on sleep quantity and quality in children and their parents, in particular for younger patients and on the first night of hospitalization.